New Delhi, July 8 -- Welcure Drugs & Pharmaceuticals share price hit 5 per cent upper circuit to Rs.12.35 in Tuesday's trading session after the company announced that it has successfully completed seven export-sourcing assignments concluded during Q1 FY 2025-26 over Rs.300 crore.

The small-cap pharma stock has given multibagger returns to its long-term investors by surging over 113 per cent in last one year and nearly 1,546.67 per cent in five years.

In a media release, the company said that it acted solely as a procurement agent and earns a fixed 5% commission on the above order. The cost of goods is settled directly by the buyers. The company remains focused on expanding its fee-based export portfolio while maintaining its debt-free ...